AVRO Old Financials

AVRO Old Stock Summary

AVRO Old competes with Enveric Biosciences, Elevation Oncology, and Zura Bio. AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

AVRO Old Key Financial Ratios

AVRO Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AVRO Old's current stock value. Our valuation model uses many indicators to compare AVRO Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AVRO Old competition to find correlations between indicators driving AVRO Old's intrinsic value. More Info.AVRO Old is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AVRO Old's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in AVRO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVRO Old's history and understand the potential risks before investing.